Investor Relations

Corporate Overview

LENZ Therapeutics is a late clinical-stage company developing innovative ophthalmic pharmaceutical products that improve vision, proudly based in San Diego. Our lead program is an aceclidine based eye drop designed to restore the loss of near vision associated with presbyopia.

Latest Financial Results

Q2 2024

Quarter Ended Jun 30, 2024

News Icon

Latest News

LENZ Therapeutics Announces Presentations at Upcoming Ophthalmology and Optometry Medical Conferences

Events Icon

Upcoming Event

Eyecelerator at the 2024 American Academy of Ophthalmology (AAO) Annual Meeting

IR Contacts

Corporate

LENZ Therapeutics, Inc.
201 Lomas Santa Fe Drive
Suite 300
Solana Beach, CA 92075
T: (888) 928-LENZ (5369)
contact@lenz-tx.com

Investor Relations

LENZ Therapeutics
IR@LENZ-Tx.com

Stern Investor Relations, Inc.
Janhavi Mohite
janhavi.mohite@sternir.com

Transfer Agent

Equiniti Trust Company, LLC
48 Wall Street
New York, NY 10005
T: 800-937-5449

Connect With Us